Q&A: Fecal transplant appears effective for immunotherapy-induced colitis

Fecal microbiota transplantation may be a viable treatment option for patients with cancer who have developed immunotherapy-induced colitis, according to results of a case series published in Nature Medicine.
FMT has been shown to be effective in treating patients with Clostridium difficile infections and inflammatory bowel disease but has not previously been tested as a treatment option in patients with cancer who have developed gastrointestinal side effects as a result of their immunotherapy.
Immunotherapy-induced colitis, the second most common side effect from immune checkpoint inhibitors,

Source link

Related posts

Dual Biologic Therapy in Inflammatory Bowel Disease


Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database


Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy